{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:50:44Z","timestamp":1780062644101,"version":"3.54.0"},"reference-count":59,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:p>\n                    A cell-surface ectonucleotidase CD39 mediates the conversion of extracellular adenosine triphosphate into immunosuppressive adenosine with another ectonucleotidase CD73. The elevated adenosine in the tumor microenvironment attenuates antitumor immunity, which promotes tumor cell immunologic escape and progression. Anti-CD39 monoclonal antibodies (mAbs), which suppress the enzymatic activity, can be applied to antitumor therapy. Therefore, an understanding of the relationship between the inhibitory activity and epitope of mAbs is important. We previously established an anti-mouse CD39 (anti-mCD39) mAb, C\n                    <jats:sub>39<\/jats:sub>\n                    Mab-1 using the Cell-Based Immunization and Screening method. In this study, we determined the critical epitope of C\n                    <jats:sub>39<\/jats:sub>\n                    Mab-1 using flow cytometry. We performed the PA tag (12 amino acids [aa])-substituted analysis (named PA scanning) and RIEDL tag (5 aa)-substituted analysis (named RIEDL scanning) to determine the critical epitope of C\n                    <jats:sub>39<\/jats:sub>\n                    Mab-1 using flow cytometry. By the combination of PA scanning and RIEDL scanning, we identified the conformational epitope, spanning three segments of 275\u2013279, 282\u2013291, and 306\u2013323 aa of mCD39. These analyses would contribute to the identification of the conformational epitope of membrane proteins.\n                  <\/jats:p>","DOI":"10.1089\/mab.2023.0029","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T16:07:51Z","timestamp":1710950871000},"page":"44-52","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Epitope Mapping of an Anti-Mouse CD39 Monoclonal Antibody Using PA Scanning and RIEDL Scanning"],"prefix":"10.1177","volume":"43","author":[{"given":"Yuki","family":"Okada","sequence":"first","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika K.","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-8201","authenticated-orcid":false,"given":"Yukinari","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.206"},{"key":"e_1_3_6_3_2","article-title":"Lytic release of cellular ATP: Physiological relevance and therapeutic applications","volume":"11","author":"Grygorczyk R","year":"2021","unstructured":"Grygorczyk R, , Boudreault F, , Ponomarchuk O, et al. Lytic release of cellular ATP: Physiological relevance and therapeutic applications. Life (Basel), 2021; 11; doi: 10.3390\/life11070700","journal-title":"Life (Basel)"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0037-0"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.86"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113066"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01733-x"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.04.091"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0376-4"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00500-w"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0541"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45040238"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098411"},{"key":"e_1_3_6_14_2","article-title":"Development of a novel anti-CD44 variant 8 monoclonal antibody C(44)Mab-94 against gastric carcinomas","volume":"12","author":"Suzuki H","year":"2023","unstructured":"Suzuki H, , Goto N, , Tanaka T, et al. Development of a novel anti-CD44 variant 8 monoclonal antibody C(44)Mab-94 against gastric carcinomas. Antibodies (Basel), 2023; 12; doi: 10.3390\/antib12030045","journal-title":"Antibodies (Basel)"},{"key":"e_1_3_6_15_2","article-title":"Development of a novel anti-CD44 variant 5 monoclonal antibody C(44)Mab-3 for multiple applications against pancreatic carcinomas","volume":"12","author":"Kudo Y","year":"2023","unstructured":"Kudo Y, , Suzuki H, , Tanaka T, et al. Development of a novel anti-CD44 variant 5 monoclonal antibody C(44)Mab-3 for multiple applications against pancreatic carcinomas. Antibodies (Basel), 2023; 12; doi: 10.3390\/antib12020031","journal-title":"Antibodies (Basel)"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45070333"},{"key":"e_1_3_6_17_2","article-title":"EMab-300 detects mouse epidermal growth factor receptor-expressing cancer cell lines in flow cytometry","volume":"12","author":"Goto N","year":"2023","unstructured":"Goto N, , Suzuki H, , Tanaka T, et al. EMab-300 detects mouse epidermal growth factor receptor-expressing cancer cell lines in flow cytometry. Antibodies (Basel), 2023; 12; doi: 10.3390\/antib12030042","journal-title":"Antibodies (Basel)"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24044007"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0058"},{"key":"e_1_3_6_20_2","article-title":"Development of a novel anti-EpCAM monoclonal antibody for various applications","volume":"11","author":"Li G","year":"2022","unstructured":"Li G, , Suzuki H, , Asano T, et al. Development of a novel anti-EpCAM monoclonal antibody for various applications. Antibodies (Basel), 2022; 11; doi: 10.3390\/antib11020041","journal-title":"Antibodies (Basel)"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0067"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0062"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8083"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0005"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0011"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0006"},{"key":"e_1_3_6_27_2","article-title":"Development and characterization of TrMab-6, a novel anti-TROP2 monoclonal antibody for antigen detection in breast cancer","volume":"23","author":"Sayama Y","year":"2021","unstructured":"Sayama Y, , Kaneko MK, , Kato Y. Development and characterization of TrMab-6, a novel anti-TROP2 monoclonal antibody for antigen detection in breast cancer. Mol Med Rep, 2021; 23; doi: 10.3892\/mmr.2020.11731","journal-title":"Mol Med Rep"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0007"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0015"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2020.0003"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2020.0018"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2020.100826"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11753"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2019.0002"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2019.100633"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2018.03.007"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2018.0004"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2023.0016"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2014.0091"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5339"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2014.0090"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0023"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2020.100780"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0012"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0010"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2021.0014"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2019.0045"},{"key":"e_1_3_6_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06328-6"},{"key":"e_1_3_6_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2014.01.009"},{"key":"e_1_3_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.08.171"},{"key":"e_1_3_6_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3580"},{"key":"e_1_3_6_52_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.176685"},{"key":"e_1_3_6_53_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abp9011"},{"key":"e_1_3_6_54_2","doi-asserted-by":"publisher","DOI":"10.1107\/S2059798321002527"},{"key":"e_1_3_6_55_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2022.0029"},{"key":"e_1_3_6_56_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2022.0035"},{"key":"e_1_3_6_57_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2022.0019"},{"key":"e_1_3_6_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2011.10.050"},{"key":"e_1_3_6_59_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi982426k"},{"key":"e_1_3_6_60_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2020.1838036"}],"container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mab.2023.0029","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2023.0029","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2023.0029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:22:23Z","timestamp":1777666943000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/mab.2023.0029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4,1]]}},"alternative-id":["10.1089\/mab.2023.0029"],"URL":"https:\/\/doi.org\/10.1089\/mab.2023.0029","relation":{},"ISSN":["2167-9436","2167-9436"],"issn-type":[{"value":"2167-9436","type":"print"},{"value":"2167-9436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]}}}